10x Genomics (TXG) Cash from Operations Growth (3y) (2021 - 2026)

10x Genomics (TXG) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn 30.60%
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn 45.52%
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn 45.69%
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn -
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn 102.73%
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn -
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn -
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn 32.92%
9 Privia Health 3.10 Bn 2.68 Bn - -54.61%
10 Omnicell 1.89 Bn 1.65 Bn 140.36 Mn 62.21%

Historic Data

Download Data
DateValue
Mar 31, 2026 102.73%
Dec 31, 2025 43.77%
Sep 30, 2025 86.80%
Jun 30, 2025 44.93%
Mar 31, 2025 53.99%
Dec 31, 2024 -46.78%
Sep 30, 2024 41.37%
Jun 30, 2024 33.93%
Mar 31, 2024 -56.76%
Dec 31, 2023 30.02%
Sep 30, 2023 23.09%
Jun 30, 2023 26.91%
Mar 31, 2023 -16.99%
Dec 31, 2022 27.00%
Sep 30, 2022 -38.53%
Jun 30, 2022 -83.26%
Mar 31, 2022 -61.76%
Dec 31, 2021 28.34%